MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
Journal Article

Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy

2011
Request Book From Autostore and Choose the Collection Method
Overview
Purpose We have generated transgenic mouse lines expressing the positron emission tomography (PET) reporter gene, sr39tk , under the control of the mouse insulin I promoter (MIP-sr39tk) to image endogenous islets using PET. Procedures The MIP-sr39tk transgene was constructed using the 8.3 kb fragment of the mouse insulin I promoter and the sr39tk coding sequence from the mrfp-hrl-ttk trifusion construct. Expression of sr39TK in beta cells was confirmed by fluorescence immunohistochemistry of pancreatic sections. Histological sections were used to determine beta cell mass, islet area and islet number. Beta cell function was determined using intraperitoneal glucose tolerance tests. For ex vivo biodistrubution, mice were injected i.v. with 9.25 MBq [ 18 F]fluorohydroxymethyl-butyl-guanine (FHBG), euthanized 1 h later and pancreata and other organs were collected and counted. For PET scans, mice were injected i.v. with 9.25 MBq [ 18 F]FHBG, and dynamic scans were conducted for 1 h, followed by a 30 min static acquisition. To induce type 1 diabetes-like symptoms, MIP-sr39tk mice were injected i.p. with 40 mg/kg streptozotocin (STZ) once per day for five consecutive days, and biodistribution and PET scans were conducted thereafter. Results Ex vivo quantification of [ 18 F]FHBG uptake in the pancreas showed a 4.5-fold difference in transgenic vs . non-transgenics, confirming that expression of sr39TK results in the retention of the PET tracer. In STZ-treated MIP-sr39tk mice, impairments in glucose tolerance and decreases in beta cell mass correlated significantly with a diminishment in [ 18 F]FHBG uptake before fasting hyperglycemia became apparent. Conclusions The MIP-sr39tk mouse demonstrates that PET imaging can detect changes in beta cell mass that precede the onset of diabetes.